Cargando…
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastoma
PURPOSE: Glioblastoma(GBM) is a lethal disease characterized by inevitable recurrence. Here we investigate the molecular pathways mediating resistance, with the goal of identifying novel therapeutic opportunities. EXPERIMENTAL DESIGN: We developed a longitudinal in vivo recurrence model utilizing pa...
Autores principales: | Al-Holou, Wajd N., Wang, Hanxiao, Ravikumar, Visweswaran, Shankar, Sunita, Oneka, Morgan, Fehmi, Ziad, Verhaak, Roel GW, Kim, Hoon, Pratt, Drew, Camelo-Piragua, Sandra, Speers, Corey, Wahl, Daniel R, Hollon, Todd, Sagher, Oren, Heth, Jason A, Muraszko, Karin M., Lawrence, Theodore S., de Carvalho, Ana C, Mikkelsen, Tom, Rao, Arvind, Rehemtulla, Alnawaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841165/ https://www.ncbi.nlm.nih.gov/pubmed/36621024 http://dx.doi.org/10.1016/j.neo.2022.100872 |
Ejemplares similares
-
H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in a young adult with COVID-19-associated coagulopathy
por: Pun, Matthew, et al.
Publicado: (2020) -
DDRE-19. PHASE 0/I TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH RADIATION TO OVERCOME GLIOBLASTOMA TREATMENT RESISTANCE BY TARGETING DE-NOVO PURINE METABOLISM
por: Umemura, Yoshie, et al.
Publicado: (2021) -
NEIM-08 A PHASE II STUDY OF MULTIPARAMETRIC MR-GUIDED HIGH DOSE ADAPTIVE RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
por: Kim, Michelle, et al.
Publicado: (2022) -
Budding uninhibited by benzimidazoles-1 (BUB1) regulates EGFR signaling by reducing EGFR internalization
por: Nyati, Shyam, et al.
Publicado: (2023) -
SubcloneSeeker: a computational framework for reconstructing tumor clone structure for cancer variant interpretation and prioritization
por: Qiao, Yi, et al.
Publicado: (2014)